Notably, the expression of programmed cell death ligand 1 (PD-L1) on the surface of cancer cells, a key immune checkpoint molecule, interacts with its receptor-programmed cell death (PD-1) on immune cells, and counteracts the TCR cascade through phosphorylation of PTPN11 to neutralize cytotoxic T-cell activity [4]. Here, CD274 is linked to cancer.